1. Context {#sec56015}
==========

Almost half the population in the world is infected by *H. pylori* which is the most common infecting organism affecting humans ([@A12581R1], [@A12581R2]). Since the first experience of Helicobacter culture in 2004 by Marshall and Warren, a considerable amount of information has been acquired on clinical aspects of this infection ([@A12581R3]). Helicobacter pylori is tightly associated with gastro-intestinal disorders, some important consequences of which can be chronic gastritis, peptic ulcer leading to gastric cancer, indigestion and non-ulcer dyspepsia ([@A12581R4]-[@A12581R9]).

In developing countries, the prevalence of *H. pylori* positive serology during childhood is higher than that in developed countries. This is vice versa during adulthood ([@A12581R10], [@A12581R11]). In a Meta-analysis study, the prevalence of *H. pylori* infection in China was reported as 58.07% ([@A12581R12]). In another Meta-analysis study, the association between *H. pylori* infection and the risk of esophageal cancer (EAC) has been suggested ([@A12581R13]). Also, the association between *H. pylori* infection in diabetic and non-diabetic individuals with dyspepsia was assessed. This study showed that the prevalence of *H. pylori* infection was considerably higher in diabetic patients compared to non-diabetic individuals (P = 0.001). According to these results, diabetes Mellitus is one of the risk factors that need attention in the evaluation of *H. pylori* infections among diabetic patients with dyspepsia ([@A12581R14]).

The prevalence of *H. pylori* infection was 58% among residents of two villages in Northern Italy, considerably higher than the 34% observed in an earlier similar study of adults in northern Swedish communities (mean age = 52 years). A prevalence of 60% or more was reported for groups in Albania, Egypt, Iran, Turkey, and China ([@A12581R15]). The prevalence of *H. pylori* infection was 3.0% among index children at age 4 and maternal infection was the only risk factor at multivariate analysis ([@A12581R16]).

One of the main objectives of Meta-analysis studies, which are a combination of different studies, is to reduce the difference between parameters as a result of an increase in the number of studies involved in the process of analysis and also to reduce the confidence level of these measures/figures.

The aim of this study was to investigate the studies carried out on the prevalence of *H. pylori* infection in Iran and to estimate the prevalence rate of this infection according to diagnostic methods, age group of individuals infected, gender, infection age and additional parameters.

2. Evidence Acquisition {#sec56017}
=======================

This study was a systematic review and a Meta-analysis study on the prevalence of *Helicobacter* in Iran. The findings of this research were based on the papers published in internal and external journals. The papers were selected from the databases of SID, MAGIRAN, SCOPUS, MEDLIB, Google, ISI and PUBMED. Searching of the articles was carried out using the key words: Helicobacter, prevalence, and a combination of these words. To decrease bias two authors (Sayehmiri F, Darvishi Z) did search, selection of papers and extracting data of articles independently. First, all the articles related to Helicobacter pylori in Iran were collected. At this stage, the articles possessing the relevant key words in their title or abstract were entered into the list, excluding all the other articles not relevant to the prevalence of *H. pylori.* A check list of necessary information was prepared that included: title of the article, location of the study, location of sampling, sample volume, the methods of assessing infection, the mean age of individuals infected by *H. pylori* and the total prevalence of *H. pylori*.

According to the protocol, a total of 142 articles that were carried out from 1994 to 2011 were analyzed during the primary research. The abstracts of 94 articles, out of the 142, were then analyzed and a complete review of 45 of these papers, that included the basic information required, was then carried out. Due to unavailability of the prevalence rates, some articles were omitted and a total of 30 articles were finally entered into the process of analysis ([@A12581R17]-[@A12581R46]) ([Figure 1](#fig11278){ref-type="fig"} the study flowchart).

![Study Flowchart](ircmj-16-12581-i001){#fig11278}

2.1. Statistical Analysis {#sec56016}
-------------------------

The variance of each study was calculated according to the binomial distribution. The studies were combined together according to sample size and variance. Because of the study heterogeneity, random-effect model was used to combine the studies. To assess the heterogeneity of the studies, Cochrane Q test and the I^2^ index were used. P-value of less than 5% was considered as significant in the heterogeneity test. To investigate the relationship between years of study and sample size meta-regression model was used.

Furthermore, considering the type of data analyzed, which were all prevalence rates, there was no need to determine the publication bias and to draw a funnel plot. The data were analyzed using STATA version 11.2.

3. Results {#sec56018}
==========

In the 30 papers assessed, the prevalence rate of Helicobacter pylori infection in Iran was estimated as 50.7% (95% CI: 44.4-56.9%) ([Figure 2](#fig11279){ref-type="fig"}). The lowest prevalence rate (19.2%) was related to a study in Mazandaran province, the city of Sari and the highest prevalence rate (74.27%) were reported in a study in Tehran province, the city of Tehran. Details of the papers analyzed are found in [Table 1](#tbl14438){ref-type="table"}.

![The Prevalence Rate of H. pylori Infection and its 95% Confidence Interval\
According to the year and the location of studies assessed. The midpoint of each line illustrates the prevalence rate estimated in each study. The diamond sign shows the prevalence rate throughout the country for all the studies.](ircmj-16-12581-i002){#fig11279}

###### Summary of Included Studies Evaluating the Prevalence Rate of *H. pylori* in Iran

  City                  year        Age,y           Sample Size   Diagnostic Method        Prevalence                                  95% CI   References   
  --------------------- ----------- --------------- ------------- ------------------------ ------------------------------------------- -------- ------------ ----------------------------------------
  **Kashan**            2000        4.1 ± 9.9       39            Urease                   30.8                                        45.3     16.3         Taghavi et al. ([@A12581R30])
  **Sari**              2000        7-18            400           \-                       19.2                                        23.1     15.3         Tergar Fakheri et al. ([@A12581R39])
  **Semnan**            1999                        700           Elisa                    48                                          57.1     44.3         Moradi et al . ([@A12581R22])
  **Ghazvin**           2002        54.4            125           Urease                   43.7                                        52.4     35           Hajagamohammadi et al. ([@A12581R17])
  **Sari**              2001                        394           Elisa                    64.2                                        69.1     59.7         Baba mahmoodi et al. ([@A12581R38])
  **Khorasan razavi**   2004        12-75           195           Urease                   62.56                                       69.4     55.8         Nakhaei Moghadam et al. ([@A12581R40])
  **Tehran**            2002        30.65           120           Urease                   68.3                                        76.6     60           Faghihi et al. ([@A12581R23])
  **Yazd**              2004        30-65           28            \-                       43.5                                        61.9     25.1         Benesh et al. ([@A12581R41])
  **Ghazvin**           2002        10-60           240           Elisa                    2000.5                                      86.7     1993.3       Sheikholslami et al. ([@A12581R18])
  **Tabriz**            2009        3.21 ± 8.38     116           Serology                 Children 60.3, Mothers 57.8, Fathers 37.9   61.1     42.9         Rafiei et al. ([@A12581R31])
  **Kerman**            1993        57.05           513           Urease                   56.9                                        61.2     52.6         Zojajy ([@A12581R19])
  **Tehran**            2002        8.8 ± 48        576           Endoscopy                59.7                                        63.7     55.7         Yasseri ([@A12581R24])
  **Tehran**            2004        2.2 ± 24        137           Elisa                    65.57                                       75.3     56.7         Sharifian et al. ([@A12581R32])
  **Tehran**            2004-2006   6-12            1665          Urease                   26                                          28.1     23.9         Zamani et al. ([@A12581R25])
  **Tehran**            2003        \-              170           Histopathology           29.4                                        36.2     22.6         Barati et al. ([@A12581R26])
  **Tabriz**            \-          \-              120           \-                       71.6                                        2000.7   63.5         Rahnama et al. ([@A12581R43])
  **Tabriz**            \-          \-              86            \-                       42.6                                        53.1     32.1         Rafeey et al. ([@A12581R44])
  **Tabriz**            2003        0.03 ± 8.3      96            \-                       64.6                                        74.2     55           Modaresi et al. ([@A12581R45])
  **Kurdistan**         2006        14.91 ± 15.32   1503          Elisa                    36.5                                        38.9     34.1         Yazdanpanah et al. ([@A12581R33])
  **Tehran**            2006        39              152           \-                       35.52                                       43.1     27.9         Shokohizadeh et al. ([@A12581R46])
  **Tehran**            2010        43.9            311           \-                       74.27                                       2000.1   69.4         Neshandar et al. ([@A12581R34])
  **Kashan**            2007        17.13 ± 43.3    100           Elisa                    66                                          75.3     56.7         Arj et al. ([@A12581R20])
  **Tehran**            2003        11.67 ± 39.68   50            Urease, IgG, Histology   70                                          2003.7   57.3         Baghaei et al. ([@A12581R42])
  **Isfahan**           2010        16-62           100           PCR                      30                                          39       21           Salehi et al. ([@A12581R27])
  **Guilan**            2004        11.30 ± 32.38   50            Elisa                    54                                          67.8     40.2         Ghanei et al. ([@A12581R28])
  **Tehran**            2001                        100           Urease, Pathology        57                                          66.7     47.3         Gottaslou et al. ([@A12581R29])
  **Guilan**            2005        7-11            961           Elisa                    40                                          43.1     36.9         Mansor et al. ([@A12581R35])
  **Tehran**            2001        48.3            1993          Citology                 58.3                                        69.7     46.9         Vahidi et al. ([@A12581R36])
  **Isfahan**           2002                        70            Elisa                    44.44                                       56.1     32.8         Sanei et al. ([@A12581R21])
  **Khorasan razavi**   2006        4.77 ± 23.50    187           Elisa                    34.7                                        41.5     27.9         Dolatian et al. ([@A12581R37])
  \-                    \-          \-              \-            \-                       50.7                                        56.9     44.4         \-

In one classification, analysis was carried out based on the diagnostic methods. The sensitivity level of ELISA, according to this analysis, was estimated as 52.3% (95% CI: 43.8-60.8), the sensitivity of the urease method as 51.9% (95% CI: 36.9-66.9) and other diagnostic methods including touch cytology, histopathology as 45.8% (95% CI: 31.3-60.4). These results show that ELISA and urease are relatively more accurate methods to diagnose *H. pylori* infection ([Table 2](#tbl14439){ref-type="table"}).

In another classification, the individuals under assay were divided into the two groups of symptomatic and non-symptomatic individuals. The prevalence rate of infection among individuals with digestive disease symptoms, with a sample size of 1873 individuals, was estimated as 47.6% (95% CI: 56.1-39.2) and among healthy individuals, with a sample size of 7131 individuals, as 53.1% (95% CI: 45.4-60.8). Based on gender, the prevalence rate was estimated as 37.7% (95% CI: 95% CI: 27.5-48) in females and 35.7% (95% CI: 19.6-51.7) in males. In analysis based on the age groups, the prevalence rate among the age group below 20 years was estimated as 38.3% (95% CI: 28.1-48.5), among the age group between 20-40 years as 50.3 % (95% CI: 39.5-61) and among the age group above 40 as 60.1% (95% CI: 52.4-67.8). In this analysis, a significant difference was found among the three age groups which can be evidence to the conclusion that the rate of *H. pylori* infection increases as the age increases ([Table 3](#tbl14440){ref-type="table"}).

###### Prevalence Rate of *H. pylori* Infection in Iran According to Different Diagnostic Methods

  Diagnostic Methods          Study, No.   *H. pylori*, %, 95% CI
  --------------------------- ------------ ------------------------
  **Total Recognize group**   30           50.7 (44.4-56.9)
  **ELISA**                   10           52.3 (43.8-60.8)
  **Urease test**             8            51.9 (36.9-66.9)
  **Other methods**           5            45.8 (31.3-60.4)

###### Prevalence Rate of *H. pylori* Infection in Iran According to Health Status, Age and Gender

                   Study, No.   *H. pylori*, %, 95% CI
  ---------------- ------------ ------------------------
  **Total**        30           50.7 (44.4-56.9)
  **Sex**          \-           \-
  Women            5            37.7 (27.5-48)
  Men              5            35.7 (19.6-51.7)
  **Population**   \-           \-
  Patient          17           47.6 (39.2-56.1)
  Healthy          13           53.1 (45.4-60.8)
  **Age, y**       \-           38.3 (28.1-48.5)
  ≤ 20             6            50.3 (39.5-61)
  20-40            7            60.1 (52.4-67.8)
  \> 40            6            \-

The [Figure 3](#fig11280){ref-type="fig"} shows the relationship between the prevalence of *H. pylori* infection and year of study, and sample size using meta regression models. In [Figure 3 A](#fig11280){ref-type="fig"} the negative slope of the meta regression line showed that the prevalence of *H. pylori* infection in Iran has had a decreasing trend with a slow slop but it was not significant. In [Figure 3 B](#fig11280){ref-type="fig"} the relation between sample size was compared to the prevalence rate of *H. pylori* infection and according to this [figure](#fig11280){ref-type="fig"} there isn't a significant relation between the sample size and prevalence (P = 0.06). At the following [figure](#fig11280){ref-type="fig"} the circles show the weight of studies and it seems that studies with greater sample sizes are more prevalent and vice versa ([Figure 3](#fig11280){ref-type="fig"}). In the [Table 4](#tbl14441){ref-type="table"}, a summary of data related to meta-regression curves are shown.

![*H. pylori* Prevalence Rate According to the Year of Study and Sample Size\
The fitted line show meta-regression line.](ircmj-16-12581-i003){#fig11280}

###### The Unadjusted and Adjusted Regression Coefficients and Corresponding P Values for Correlation Between Potential Influential Factors and *H. pylori* Prevalence Using meta-Regression Models

  Factors                       Regression Coefficients   P
  ----------------------------- ------------------------- ---------
  **Year of data collection**   \-                        \-
  Unadjusted                    -0.00332003004            0.707
  Adjusted                      0.0086586                 0.21999
  **Age group**                 \-                        \-
  Unadjusted                    0.1077322                 0.017
  Adjusted                      0.1222877                 0.008
  **Sample size**               \-                        \-
  Unadjusted                    -0.0001338                0.060
  Adjusted                      -0.000919                 0.159

To assess publication bias we used funnel plot ([Figure 4](#fig11281){ref-type="fig"}) that it showed there was a significant publication bias (P = 0.016). In another classification, the analysis was carried out based on the city of the study, according to which the highest prevalence rate (61.7%), with a sample size of 245 individuals, was related to Ghazvin province (95% CI: 26.6-96.8) and the lowest prevalence rate (36.5%), with a sample size of 73 individuals, was related to Kurdistan province (95% CI: 38.9-34.1) ([Table 5](#tbl14442){ref-type="table"}).

![Funnel Plot to Assess Publication Bias](ircmj-16-12581-i004){#fig11281}

###### Prevalence Rate of *H. pylori* in Iran According to City

  City                  Random Effects OR, 95% CI   I^2^, %   Sample Size   Study, No.
  --------------------- --------------------------- --------- ------------- ------------
  **Kashan**            48.9 (14.4-2004.3)          93.8      139           2
  **Sari**              41.8 (-0.025-0.86)          99.5      20004         2
  **Semnan**            48 (44.3-51.7)              \-        700           1
  **Ghazvin**           61.7 (26.6-96.8)            97.4      245           2
  **Khorasan Razavi**   48.6 (21.3-75.9)            96.9      32003         2
  **Tehran**            53.5 (39.1-67.8)            98.4      3295          10
  **Yazd**              43.5 (25.1-61.9)            \-        28            1
  **Tabriz**            57.9 (45.3-70.5)            86.6      418           4
  **Kerman**            56.9 (52.6-61.2)            \-        513           1
  **Kurdistan**         36.5 (34.1-38.9)            73        1503          1
  **Isfahan**           36.7 (22.6-50.8)            73.4      170           2
  **Guilan**            45.3 (32-58.6)              97.4      1011          2
  **-**                 50.7 (44.4-56.9)            \-        9198          30

4. Discussion {#sec56019}
=============

A data containing 9198 *Helicobacter pylori*-infected individuals were included in the current study. A total of 30 papers were entered into the final Meta-analysis. I^2^ statistics showed a high variation among studies results (I^2^ = 97.4, P = 0.000). In three studies, including those carried out in Gilan, Sari and Qazvin, sampling had been carried out in villages as well as in cities ([@A12581R17], [@A12581R33], [@A12581R38]). The prevalence rate of *H. pylori* was calculated for all the individuals in all the age groups, based on the status of the individuals, gender and age groups.

In our review, random effect models were used for meta-analysis, considering the possibility of significant heterogeneity between studies which was tested with the Q test.

According to this model, it is assumed that individual studies are estimating different treatment effect. Another study performed by the research team of Eslami and colleagues focused on the association between *H. pylori* infection and the risk of esophageal cancer (EAC) ([@A12581R13]). In a Meta-analysis study carried out in China in 2003, the pooled prevalence rate of *H. pylori* infection in Chinese population was estimated as 58.07%, 50% of which was related to the age group of 10-20 years. This Meta-analysis has been extracted from the articles published during the years 1990-2002. In this study, infection with *H. pylori* has been reported to be a risk factor for the development of digestive system disorders ([@A12581R12]). In the study of Kashani and his colleagues, the co-existence of *H. pylori* with non-ulcer dyspepsia has been assessed in different groups of patients. In this study, no significant correlation was found between *H. pylori* infections and dyspepsia ([@A12581R23]). In the study of Zamani and colleagues, there was a significant difference in the prevalence rate of *H. pylori* infection among males and females ([@A12581R25]). In another study in Tabriz city, the relationship between the prevalence rate of *H. pylori* infection among children and their parents was evaluated. This study showed that the infection of parents, especially mothers, has a key role in the transmission of infection into their children and that aging, due to increased environmental exposure, would increase the risk of *H. pylori* infection. According to the results of this study, Father's age and job and mother's serology and literacy are important factors in the infection of the child with *H. pylori* ([@A12581R10]). In the study of Sharifian and his colleagues, carried out on the students of medicine and dentistry, it was found that the prevalence rate of *H. pylori* infection among individuals with digestive illness was lower and that the prevalence rate of *H. pylori* does not increase with an increase in the duration of dental work ([@A12581R32]).

In a study carried out in Sari in 132001, a significant correlation was reported between the prevalence rate of infection and home ownership and the family size ([@A12581R38]). In the study by Azevedo et al. the major risk factors that have been emphasized were the socioeconomic indicators ([@A12581R15]).

Among the limitations of the current study, the following can be mentioned:

1.  There was not same method to measure variables and diagnostic tests among all studies as well as,

2.  The majority of the studies were carried out in a preselected population (blood donors, individuals referring to health care centers and etc.).

3.  In most studies, nutritional status and life style were not considered as influencing factors.

4.  The range of age groups was considerably wide among different studies.

This study aimed to determine the prevalence rate of *H. pylori* infection in Iran. Almost half the population in Iran is infected by *H. pylori*, the prevalence rate being different among different parts of the country. According to the findings of this study, it is suggested that, to prevent the spread of *H. pylori*, comprehensive health programs should be scheduled throughout the country. According to the results of this study, the risk of *H. pylori* infection significantly increases with age, and so, it is recommended that preventive procedures are more seriously followed for high risk age groups. It is also recommended that the ELISA and urease tests are used in diagnostic laboratories to increase the accuracy and perception of diagnostic methods.

Funnel plot ([Figure 4](#fig11281){ref-type="fig"}) showed the effects of publication bias was significant in this study. Publication bias is very important in randomized clinical trials and case control studies, but it is not important in the meta-analysis that estimates prevalence publication bias.
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